Tirzepatide raised it
It could contribute to curbing the increase of obesity-related illnesses, which chop off as many as seven years from the life span
Lim U, Ernst T, Buchthal SD, Latch M, Albright CL, Wilkens LR, et al
Clinical trials demonstrate that meaningful weight reductiontypically defined as 5% or more of initial body weightgenerally occurs over 36 months
The SURPASS trial series (SURPASS 1-5) and SURMOUNT series provide granular data across diverse populations including patients with cardiovascular disease, chronic kidney disease, and diabetes making Tirzepatide the more data-rich compound for translational research applications
It works to suppress appetite and slow digestion, increase fat metabolism, and increase insulin sensitivity